Maintenance Notice (11:50 AM - 2:10 PM August 29, 2026): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.202 | Product Document Searching Made Easy by 2D Code! | [Product Highlights] Easy-to-Use Membrane Protein...
Maximum quantity allowed is 999
CAS RN: 511296-88-1 | Product Number: C2826
Cyclic Pifithrin-α Hydrobromide
Purity: >98.0%(HPLC)
- 2-(p-Tolyl)-5,6,7,8-tetrahydroimidazo[2,1-b]benzothiazole Hydrobromide
| Size | Unit Price | Saitama (Kawaguchi) | Hyogo (Amagasaki) | Stock in other WH |
Shipping Information
|
|---|---|---|---|---|---|
| 100MG |
¥115,000
|
5 | It can be shipped from Saitama warehouse on the same day* | Contact Us |
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | C2826 |
Purity / Analysis Method
|
>98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__1__6N__2S·HBr = 349.29 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Frozen (<0°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Air Sensitive,Heat Sensitive |
| CAS RN | 511296-88-1 |
| PubChem Substance ID | 253659530 |
| Merck Index (14) | 7421 |
| MDL Number | MFCD02683960 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| NMR | confirm to structure |
References
- Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic β-cell function in diabetes
- Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart
References
- 1)Assessing TP53 status in human tumours to evaluate clinical outcome
- 2)Two supporting factors greatly improve the efficiency of human iPSC generation
- 3)Suppression of Induced pluripotent stem cell generation by the p53-p21 pathway
- 4)The Ink4/Arf locus is a barrier for iPS reprogramming
- 5)Linking the p53 tumour suppressor pathway to somatic cell reprogramming
- 6)Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
- 7)A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
- 8)p53, Stem cells, and reprogramming: tumor suppression beyond guarding the genome
- 9)A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.